FATE THERAPEUTICS DL-,001 earnings per share and revenue

F6T earnings per share for the last quarter are -0.44 EUR whereas the estimation was -0.44 EUR which accounts for 0.38% surprise. Company revenue for the same period amounts to 1.78 M EUR despite the estimated figure of 1.54 M EUR. Estimated earnings per share for the next quarter are -0.43 EUR, and revenue is expected to reach 1.22 M EUR. Also watch annual changes over time to get a bigger picture of F6T earnings per share and revenue dynamics.